Inflammation | Proliferation | Remodeling
Healing Phases
Critical Must-Knows
- Similar to tendon healing - three overlapping phases
- Type III collagen first, gradually replaced by Type I
- Never achieves normal properties - healed ligament weaker than original
- Intra-articular ligaments heal poorly (ACL) vs extra-articular (MCL) heal well
- Controlled motion beneficial for ligament healing
Clinical Pearls
- "MCL heals well (extra-articular), ACL does not (intra-articular)
- "ACL fails to heal due to synovial fluid, lack of blood supply, gap
- "Healed MCL 50-70% of normal tensile strength
- "Similar phases to tendon: inflammation, proliferation, remodeling
Critical Ligament Healing Exam Points
Healing Phases
Inflammatory (0-1 week): Hematoma, inflammatory cells, growth factors. Proliferative (1-6 weeks): Fibroblasts, Type III collagen. Remodeling (6 weeks+): Type I collagen, cross-linking.
ACL vs MCL Healing
MCL heals well - extra-articular, blood supply, contained hematoma. ACL heals poorly - intra-articular, synovial fluid washes away clot, poor blood supply, retraction.
Collagen Transition
Type III collagen produced initially (thin, disorganized). Replaced by Type I during remodeling (thick, organized). Cross-links form. Never achieves normal properties.
Mechanical Properties
Healed ligament achieves 50-70% of normal tensile strength at best. Increased cross-sectional area compensates. Stiffness also reduced. Functional recovery possible.


SGRBACL Healing Failure
| S | Synovial fluid Washes away hematoma and growth factors |
| G | Gap formation Ends retract, no scaffold for healing |
| R | Reduced blood supply Intra-articular location, poor vascularity |
| B | Biological factors Insufficient intrinsic healing capacity |
| S | Synovial fluid Washes away hematoma and growth factors | R | Reduced blood supply Intra-articular location, poor vascularity |
| G | Gap formation Ends retract, no scaffold for healing | B | Biological factors Insufficient intrinsic healing capacity |
Hook:SGRB = Synovial fluid, Gap, Reduced blood, Biology explain ACL healing failure!
CHEBMCL Healing Success
| C | Contained hematoma Extra-articular location retains clot |
| H | Hematoma provides scaffold Matrix for healing cells |
| E | Extra-articular location No synovial fluid interference |
| B | Blood supply adequate Periligamentous tissues contribute |
| C | Contained hematoma Extra-articular location retains clot | E | Extra-articular location No synovial fluid interference |
| H | Hematoma provides scaffold Matrix for healing cells | B | Blood supply adequate Periligamentous tissues contribute |
Hook:CHEB = Contained Hematoma, Extra-articular, Blood supply explain MCL healing!
Overview
Ligament healing follows similar principles to tendon healing but with important differences based on anatomical location. Extra-articular ligaments like the MCL heal reliably, while intra-articular ligaments like the ACL do not heal and require surgical reconstruction if normal function is to be restored.
Clinical Relevance
Understanding why some ligaments heal and others do not guides treatment decisions. MCL injuries are typically managed non-operatively. ACL injuries require reconstruction in active patients. Healing biology informs rehabilitation protocols.
Mechanisms - Healing Phases
Inflammatory Phase (Days 0-7)
Ligament injury triggers an inflammatory response. Hematoma forms and serves as scaffold for healing. Inflammatory cells arrive and release cytokines and growth factors. This phase is essential for initiating repair.
For extra-articular ligaments like the MCL, the hematoma is contained and provides a stable scaffold. For intra-articular ligaments like the ACL, synovial fluid disperses the hematoma and growth factors, disrupting this critical first step.
Proliferative Phase (Weeks 1-6)
Fibroblasts migrate into the healing zone and proliferate. Type III collagen synthesis begins. Granulation tissue forms. The healing tissue is highly cellular and disorganized. Mechanical strength is minimal during this phase.
Remodeling Phase (Weeks 6 to Years)
Type III collagen is gradually replaced by Type I collagen. Collagen fibers align along stress lines. Cross-links form between collagen molecules. Cellularity decreases. Mechanical properties improve but never return to normal.
Why Does ACL Not Heal?
The ACL fails to heal because: (1) Synovial fluid prevents clot formation and washes away growth factors, (2) The torn ends retract creating a gap with no scaffold, (3) Intra-articular blood supply is limited, (4) The ACL lacks the capacity for intrinsic repair seen in extra-articular ligaments.
Clinical Relevance - MCL vs ACL
MCL Healing (Extra-articular)
The MCL heals predictably with conservative management in most cases. The extra-articular location allows hematoma formation and containment. Periligamentous tissues provide blood supply. The healing MCL is enlarged but functional.
Management: Protected motion, hinged brace, rehabilitation. Surgery rarely needed for isolated MCL injuries. Valgus stress protected during healing.
Outcome: Functional recovery expected. Healed MCL has 50-70% of normal tensile strength but increased cross-sectional area. Most patients return to function.
ACL Healing (Intra-articular)
The ACL does not heal spontaneously. Synovial environment is hostile to healing. Reconstruction is required to restore stability in active patients wanting to return to pivoting activities.
Why Reconstruction: The ACL cannot heal itself. Leaving the knee ACL-deficient leads to instability and risk of secondary meniscal and chondral damage. Reconstruction uses graft to replace function.
Modern Research: ACL repair (primary suture, internal bracing, or scaffold bridging as in BEAR) is being revisited for proximal/midsubstance tears with good tissue. Reconstruction remains the standard for most complete tears in pivoting athletes.
Intra-articular vs Extra-articular Healing — Side by Side
Why Location Dictates Healing Capacity
| Factor | Extra-articular (MCL) | Intra-articular (ACL) |
|---|---|---|
| Hematoma / fibrin clot | Contained — forms a healing scaffold | Dispersed by synovial fluid; no stable clot |
| Growth factors | Retained at injury site | Diluted and washed away |
| Torn-end apposition | Ends stay apposed | Ends retract, leaving a gap |
| Vascular supply | Rich periligamentous vessels | Sparse; relies on synovium and fat pad |
| Synovial environment | Absent | Hostile plasmin-rich, anti-clotting milieu |
| Typical outcome | Reliable scar healing, 50-70% strength | No spontaneous healing of complete tears |
| Default management | Non-operative (brace, protected motion) | Reconstruction (or selected repair/BEAR) |
Differential Diagnosis of Poor Ligament/Soft-Tissue Healing
When a ligament injury fails to recover as expected, the differential is broader than the index injury. Distinguish a biologically non-healing ligament (e.g. ACL) from a missed associated injury or a systemic cause of impaired healing.
Causes of Failed or Delayed Ligament Healing
| Entity | Key Discriminator | Confirmatory Clue |
|---|---|---|
| Intra-articular ligament (ACL) — expected non-healing | Synovial environment, gap, retraction | MRI shows discontinuity; persistent pivot shift |
| Unrecognised combined ligament injury (e.g. MCL + ACL/PLC) | Multidirectional or rotatory instability | Stress radiographs, examination under anaesthesia |
| Distal MCL avulsion / Stener-like (Pellegrini-Stieg later) | Superficial MCL flips superficial to pes anserinus | MRI; explains a non-healing 'grade II' MCL |
| Chronic instability with secondary damage | Recurrent giving way, effusions | MRI meniscal/chondral injury, bone bruising |
| Systemic impairment (diabetes, smoking, steroids, malnutrition) | Generalised poor wound healing | HbA1c, smoking history, nutritional markers |
| Inflammatory / connective tissue disorder (e.g. Ehlers-Danlos) | Generalised hyperlaxity, recurrent injury | Beighton score, family history |
Evidence Base
- Synthesised molecular biology and biomechanics of normal and healing rabbit MCL
- Scar matrix has flaws, smaller-than-normal collagen fibril diameters, and failed cross-link maturation
- These deficiencies explain scar weakness and increased creep despite enlarged cross-sectional area
- Joint motion and systemic hormones (pregnancy) modulate both normal and healing ligament behaviour
- Screened growth factors in vitro then applied to a transected rabbit MCL model
- PDGF-BB and EGF best stimulated fibroblast proliferation; TGF-beta1 best stimulated matrix synthesis
- High-dose PDGF-BB significantly increased ultimate load, elongation and energy-to-failure at 6 weeks (dose-dependent)
- Adding TGF-beta1 to PDGF-BB gave no further structural gain
- Porcine model of ACL reconstruction, collagen-platelet composite augmentation, and bioenhanced primary repair
- T2*-weighted MRI volume predicted healing tissue structural properties (R-squared up to 0.56)
- Combining volume and signal intensity predicted maximum load, yield load and stiffness (R-squared up to 0.73)
- Established a non-invasive surrogate for the strength of a healing ACL repair or graft
- Randomised 100 patients (median age 17) with complete midsubstance ACL tears to bridge-enhanced repair (n=65) vs autograft reconstruction (n=35)
- At 2 years BEAR was non-inferior for IKDC subjective score (88.9 vs 84.8) and AP laxity side-to-side difference (1.61 vs 1.77 mm)
- BEAR gave superior hamstring strength index (98.2% vs 63.2%)
- Reinjury requiring further ipsilateral ACL surgery: 14% BEAR vs 6% ACLR (not significant)
- First 11 consecutive patients with proximal avulsion ACL tears treated by arthroscopic suture-anchor primary repair
- At minimum 5-year follow-up 9 of 10 had IKDC objective grade A and full range of motion
- Mean Lysholm 96, subjective IKDC 92 — excellent durable scores
- Outcomes confined to carefully selected proximal tears with excellent tissue quality
- 56 consecutive arthroscopic ACL repairs, 27 with additional internal brace augmentation
- Overall failure rate 10.7% at mean 3.2-year follow-up
- Failure 7.4% with vs 13.8% without internal bracing (not statistically significant)
- 73% achieved objective IKDC grade A in a selected population
Exam Viva Scenarios
Use these scenarios to practise clinical reasoning and management decisions
Scenario 1: Why Does MCL Heal but ACL Does Not?
"An examiner asks you to explain why the MCL heals with conservative treatment while the ACL does not."
Scenario 2: Phases and Biology of Ligament Healing
"The examiner asks you to take them through the phases of ligament healing and explain why a healed ligament never matches the original."
Scenario 3: Can the ACL Heal? Repair vs Reconstruction
"A 17-year-old has a complete proximal ACL tear. The examiner asks whether the ACL can ever heal and where primary repair or bridge-enhanced repair fit against reconstruction."
MCQ Practice Points
ACL Healing Failure
Q: Why does the ACL fail to heal? A: Intra-articular location, synovial fluid disperses hematoma, torn ends retract, poor blood supply. No scaffold forms for healing and growth factors are washed away.
MCL Healing Strength
Q: What percentage of normal tensile strength does a healed MCL achieve? A: 50-70% of normal. The healed MCL compensates with increased cross-sectional area. Functional recovery is expected despite inferior tissue quality.
Healing Phases
Q: What are the three phases of ligament healing? A: Inflammatory (0-1 week), Proliferative (1-6 weeks), Remodeling (6 weeks+). Same as tendon healing with Type III to Type I collagen transition.
Controversies & Areas of Uncertainty
- Does the ACL truly never heal? The BEAR II trial shows engineered intra-articular healing is possible in selected young patients, but the numerically higher reinjury rate, narrow inclusion (complete midsubstance tears treated within ~45 days), and limited long-term and registry data mean reconstruction stays the default for most pivoting athletes.
- Patient selection for primary repair. Excellent outcomes are confined to proximal avulsion tears with good tissue. There is no validated, reproducible intra-operative grading of tissue quality, so selection remains subjective and operator-dependent.
- Internal bracing — protection or stress-shielding? Suture tape augmentation may protect an early repair, but it could also stress-shield the healing ligament and alter its remodelling; the BEAR II reinjury signal and small repair cohorts leave this unresolved.
- Biological augmentation (PRP, growth factors, scaffolds). Animal data (PDGF-BB, collagen-platelet composite) are encouraging, but human evidence that PRP meaningfully improves ligament healing or outcome remains inconsistent.
- Grade III MCL and combined injuries. Whether high-grade or distal (superficial-MCL avulsion / Stener-like) MCL tears, and the MCL component of combined ACL/MCL injuries, need repair or augmentation rather than bracing is still debated.
Guidelines, Registries & Global Practice
Global Epidemiology
- ACL injuries occur in roughly 30 to 80 per 100,000 person-years, concentrated in 15 to 45-year-olds and in pivoting/cutting sports; females carry a several-fold higher sport-adjusted risk.
- Isolated MCL injury is the most common knee ligament injury overall and the great majority are managed non-operatively with reliable healing.
Side-by-Side Guidance
How Major Bodies Frame Ligament Injury Management
| Body / Source | Emphasis | Practical Recommendation |
|---|---|---|
| AAOS (US) ACL clinical practice guideline | Evidence-based reconstruction for instability | Reconstruction recommended for active patients with instability; repair selected/emerging |
| BOA / BASK (UK) | Shared decision-making, rehab-first pathways | Structured rehabilitation; reconstruction if persistent functional instability |
| ESSKA (Europe) consensus | Individualised, tear-pattern based | Recognises a role for repair/augmentation in selected proximal tears; reconstruction default |
| General MCL consensus | Biology favours non-operative healing | Brace and protected motion for isolated grade I-III MCL; surgery for select distal/combined |
Registry & Outcome Signals
- National ligament/ACL registries (e.g. Scandinavian and UK datasets) track graft choice, revision and reinjury, informing graft selection and rehabilitation rather than healing biology per se.
- Emerging BEAR and primary-repair data are not yet captured at registry scale, so practice change should remain cautious.
High- vs Limited-Resource Practice
- Well-resourced settings: ready access to MRI, arthroscopic reconstruction, and increasingly repair/BEAR in selected patients, with supervised criteria-based rehabilitation.
- Limited-resource settings: non-operative management and bracing dominate; isolated MCL injuries heal reliably without surgery, and structured rehabilitation is the highest-value intervention where arthroscopy is scarce.
Management Algorithm

LIGAMENT HEALING
Clinical summary
Healing Phases
- •Inflammatory (0-1 week): Hematoma, cells
- •Proliferative (1-6 weeks): Type III collagen
- •Remodeling (6+ weeks): Type I collagen
MCL Heals Well
- •Extra-articular location
- •Contained hematoma as scaffold
- •Adequate blood supply
- •Achieves 50-70% normal strength
ACL Does Not Heal
- •Intra-articular location
- •Synovial fluid disperses clot
- •Ends retract creating gap
- •Poor blood supply
Clinical Management
- •MCL: Conservative (brace, protected motion)
- •ACL: Reconstruction if stability needed
- •Healed tissue never equals normal
- •Controlled motion aids healing